DBVT יחס מהיר DBV Tech

DBV Technologies S.A. (DBVT) ensures patent protection for its immunotherapy methods, guaranteeing high profitability and shielding its market share from generics. The company develops innovative Viaskin patches to combat peanut allergies, targeting the food immunology segment. This chart of the company's market valuation with a value of 3.87 links these achievements to patent-protected drug delivery methods and stringent regulatory oversight.

When screening issuers for financial stability, a company's ability to settle short-term obligations without liquidating inventory is critically important. This metric aggregates cash and accounts receivable, dividing them by current liabilities to assess immediate solvency. For DBV Technologies S.A. (DBVT), the creator of the innovative Viaskin patch, this indicator reflects the ability to sustain technological development without relying on warehouse stock. By analyzing the quick ratio, an investor determines the business's actual margin of safety.